On this page
SPAC accounting looks deceptively simple: a trust, two share classes, and some warrants. The industry learned otherwise through two restatement waves, first on warrant classification in 2021, then on Class A share presentation. The technical positions are now well settled, but they are unforgiving, and the de-SPAC side adds reverse recapitalization mechanics that most target finance teams have never run.
We support both sides of the structure: sponsor teams running the SPAC’s reporting from IPO onward, and targets preparing to become the public company. The issues below are the ones that decide whether your filings clear review, written with the actual answers.
Issue 01
Class A shares: temporary equity at redemption valueASC 480-10-S99
Public shareholders can redeem Class A shares for a pro rata portion of the trust. Early practice classified only part of the class in temporary equity to preserve net tangible assets above the $5,000,001 threshold. The SEC staff view that drove the 2022 restatement wave rejected that split.
The treatmentAll Class A shares subject to possible redemption are classified in temporary equity, outside permanent equity, measured at redemption value. Subsequent changes in redemption value are recognized immediately, accreted against additional paid-in capital and, once APIC is exhausted, accumulated deficit. The remeasurement does not run through earnings. Charter mechanics that could leave net tangible assets below the threshold are a disclosure and structuring matter, not a reason to leave shares in permanent equity.
What we do: We set up the temporary equity presentation and the accretion mechanics correctly from the IPO, so it never becomes a restatement.
Issue 02
Warrant classification: public versus private placementASC 815-40
The April 2021 SEC statement on SPAC warrants forced hundreds of restatements. The core problems: settlement provisions that vary with the holder of the warrant, and tender-offer settlement features, both of which break equity classification.
The treatmentRun indexation and equity classification under ASC 815-40 instrument by instrument. Private placement warrants whose settlement terms depend on who holds them (typical cashless-exercise rights that fall away on transfer) fail the indexation guidance and are liabilities remeasured at fair value through earnings each period. Public warrants can achieve equity classification if their terms avoid the holder-dependent and net-cash-settlement traps, but each contract is read on its own words. Liability-classified warrants also pull a share of IPO issuance costs into expense rather than equity. Get the fair value methodology (listed price for public warrants where available, a model for private) documented at inception and refreshed quarterly.
What we do: We write the warrant classification memo before your first 10-Q and agree the valuation approach with your auditors up front, so quarterly marks are routine.
From our engagements: On SPAC platforms we supported from IPO, the warrant memo was written before the first 10-Q, with the valuation approach agreed with the auditors up front. Quarterly marks then became mechanical instead of contentious.
Issue 03
Trust accounting, taxes, and the 1% excise taxTrust & ASC 740
The trust holds government money market funds or Treasuries, generating income the SPAC cannot freely spend but must account for. Since 2023, redemptions and certain repurchases also sit within the stock buyback excise tax, which many sponsor teams did not expect to touch a shell company.
The treatmentTrust assets are presented as investments held in trust, with interest and dividend income recognized as earned. That income is taxable, so the SPAC records a current tax provision even with no operating business, and franchise taxes accrue alongside. Amounts permitted to be withdrawn for taxes are disclosed. For the excise tax, a 1% liability is accrued on covered redemptions, recorded against equity rather than earnings, with the analysis updated at each redemption event, extension vote, and at liquidation, where statutory dissolution mechanics can change the answer. Disclose the accrual and who bears it, because target-side negotiators ask.
What we do: We handle the trust income presentation, the tax provision, and the excise tax accrual, updated at each redemption and extension event.
Issue 04
Going concern with a countdown clockASC 205-40
A SPAC has a contractual deadline to complete a combination or liquidate. Once that date sits within twelve months of the financial statement issuance date, the going-concern evaluation is automatic, regardless of how much cash sits in trust.
The treatmentThe mandatory liquidation date within the assessment window is a condition that raises substantial doubt, and completion of a business combination is not within management’s sole control, so it generally cannot alleviate the doubt on its own. The result is standard disclosure language describing the deadline, extension mechanics, and liquidation consequences. Extensions funded by sponsor deposits change the dates but repeat the analysis. Treat it as a recurring disclosure exercise with real dates, not boilerplate; reviewers check the math against the charter.
What we do: We draft the going-concern disclosure against your actual charter dates and keep it current through each extension.
Working through one of these on a live deal? Talk to us before it holds up your closing.
Talk to an Expert
Issue 05
Founder shares, anchor allocations, and IPO cost allocationASC 718 / SAB Topic 5A
Class B founder shares are issued for nominal consideration, sometimes transferred to directors or sold alongside anchor investments in the IPO. Each variation has its own accounting, and the IPO cost allocation interacts with warrant classification.
The treatmentFounder shares held by the sponsor as promote are not compensation by default, but shares transferred to directors, officers, or advisors are share-based payments measured at fair value under ASC 718, with expense timing driven by vesting and, where vesting depends on a business combination, recognized when that performance condition is achieved. Founder shares attached to anchor investor allocations are measured at fair value and treated as an offering cost of the IPO. Issuance costs are then allocated between instruments: the portion allocated to liability-classified warrants is expensed immediately, and the remainder is charged against the Class A shares in temporary equity.
What we do: We analyze founder shares, director transfers, and anchor allocations, and set the IPO cost allocation, so compensation and offering costs land in the right place.
Issue 06
De-SPAC: reverse recapitalization versus business combinationASC 805 / 810
When the merger closes, someone is the accounting acquirer, and it is usually not the SPAC. The determination controls whether the transaction creates goodwill or is treated as the target issuing shares for the SPAC’s cash.
The treatmentAssess control of the combined company: relative voting rights, board composition, management continuity, and which shareholder group dominates. When the target’s holders control the combined entity, the deal is a reverse recapitalization: the target is the accounting acquirer, the historical financial statements become the target’s, the SPAC’s net assets come over at carrying value, and no goodwill arises. Share counts and EPS for all periods presented are retroactively restated using the exchange ratio. Target transaction costs that are direct and incremental to the equity issuance are charged to APIC; costs that are not, and the SPAC’s own costs, are expensed. A minority of deals where the SPAC-side holders end up in control are true business combinations under ASC 805, with purchase accounting and goodwill.
What we do: We run the accounting-acquirer analysis, recast the financials and EPS by the exchange ratio, and prepare the transaction accounting before signing, not after.
From our engagements: We have carried targets in critical minerals and security screening technology through this exact sequence: acquirer analysis, recast financials, exchange-ratio EPS, and the Super 8-K filed on the fourth business day. The calendar is the hard part; the positions should be settled before signing.
Issue 07
Earnout shares and sponsor vestingASC 815-40
De-SPAC deals routinely include earnout shares released to selling shareholders, or sponsor shares that re-vest, when the stock hits price milestones. Classification determines whether the company carries a mark-to-market liability against its own share price for years.
The treatmentEarnouts to selling shareholders in a reverse recapitalization are evaluated as freestanding instruments under ASC 815-40. Arrangements indexed only to the company’s own share price, settled solely in shares, generally achieve equity classification: recognized once at fair value with no remeasurement. Features tied to anything else, a change-of-control cash-out at a fixed price, holder-specific terms, or settlement alternatives, push the instrument to liability classification with fair value remeasurement through earnings. Earnouts to parties providing employment are compensation under ASC 718 with market-condition valuation. The fair value work is Monte Carlo territory; scope the valuation specialist at signing.
What we do: We review the earnout terms before signing, reach the classification conclusion, and scope the valuation specialist so there are no surprises at closing.
Issue 08
The Super 8-K and the first quarters as a public companyReporting
Four business days after closing, the combined company files an 8-K carrying Form 10 level disclosure: audited target financials, pro formas, MD&A, and the full item set. The first 10-Q lands weeks later on public-company timelines the target has never operated under.
The treatmentTreat the Super 8-K as the S-1 you never filed: PCAOB-audited target financial statements for the required periods, Article 11 pro forma information reflecting the recapitalization and redemptions, MD&A written to registrant standard, and the transaction accounting positions (acquirer analysis, earnouts, warrants assumed) already papered. Then stand up the quarterly machine immediately: close calendar, disclosure checklist, EPS with the retroactive exchange ratio, and segment and instrument disclosures that match the 8-K. Companies that scramble the first 10-Q spend the next year explaining it.
What we do: We prepare the Super 8-K financial statements, pro formas, and MD&A, and stand up your quarterly reporting, so the first 10-Q is not a scramble.